Complete Atrioventricular Block as a First Presentation of Arrhythmogenic Right Ventricular Cardiomyopathy in a Middle-Aged Male: A Nouvel Clinical Entity

H. Bendahou

Department of Cardiology P37, Ibn Rochd University Hospital, Casablanca, Morocco.

M. Njie *

Department of Cardiology P37, Ibn Rochd University Hospital, Casablanca, Morocco.

Y. Ettagmouti

Department of Cardiology P37, Ibn Rochd University Hospital, Casablanca, Morocco.

M. Haboub

Department of Cardiology P37, Ibn Rochd University Hospital, Casablanca, Morocco and Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco.

S. Arous

Department of Cardiology P37, Ibn Rochd University Hospital, Casablanca, Morocco and Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco.

G. Bennouna

Department of Cardiology P37, Ibn Rochd University Hospital, Casablanca, Morocco and Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco.

A. Drighil

Department of Cardiology P37, Ibn Rochd University Hospital, Casablanca, Morocco and Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco.

L. Azzouzi

Department of Cardiology P37, Ibn Rochd University Hospital, Casablanca, Morocco and Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco.

R. Habbal

Department of Cardiology P37, Ibn Rochd University Hospital, Casablanca, Morocco and Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca, Morocco.

*Author to whom correspondence should be addressed.


Abstract

Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is arare inherited cardiac disease that presents with progressive right ventricular (RV) dysfunction due to fibro-fatty replacement of the myocardium and associated with an elevated risk of ventricular arrhythmias and sudden cardiac death. ARVC/D has a predominantly autosomal dominant inheritance, although recessive forms associated with a cutaneous phenotype, such as Naxos disease and Carvajal syndrome, are also observed. The golden standard for diagnosing ARVC/D is an endomyocardial biopsy demonstrating fibro-fatty replacement. Our case concerns a middle-aged male patient with rare bradyarrhythmia (complete atrioventricular block) associated with signs and symptoms of right heart failure who was diagnosed with arrhythmogenic right ventricular cardiomyopathy ARVC died shortly upon admission at the emergency department.

Keywords: Complete atrioventricular block, arrhythmogenic right ventricular cardiomyopathy / dysplasia, task force criteria


How to Cite

Bendahou , H., M. Njie, Y. Ettagmouti, M. Haboub, S. Arous, G. Bennouna, A. Drighil, L. Azzouzi, and R. Habbal. 2023. “Complete Atrioventricular Block As a First Presentation of Arrhythmogenic Right Ventricular Cardiomyopathy in a Middle-Aged Male: A Nouvel Clinical Entity”. Asian Journal of Cardiology Research 6 (1):183-89. https://journalajcr.com/index.php/AJCR/article/view/156.

Downloads

Download data is not yet available.

References

Danielle E Burghouwt, Janneke AE Kammeraad, Paul Knops, Frederik A du Plessis, Natasja MS de Groot. Bradyarrhythmias: First presentation of arrhythmogenic right ventricular cardiomyopathy? J Clin Med Res. 2015; 7:278-281.

Hamilton RM, Fidler L. Right ventricular cardiomyopathy in the young: An emerging challenge. Heart Rhythm. 2009;6:571-575.

Den Haan AD, Tan BY, Zikusoka MN, Llado LI, Jain R, Daly A, Tichnell C, et al. Comprehensive desmosome mutation analysis in north americans with arrhythmogenic right ventricular dysplasia/ cardiomyopathy. Circ Cardiovasc Genet. 2009;2:428-435.

Quarta G, Muir A, Pantazis A, Syrris P, Gehmlich K, Garcia-Pavia P, Ward D, et al. Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria. Circulation. 2011;123 n:2701-2709.

Peters S, Trummel M, Koehler B, Westermann KU.Mechanisms of syncopes in arrhythmogenic right ventricular dysplasia-cardiomyopathy beyond monomorphic ventricular tachycardia. Int J Cardiol. 2006;106 :52-54.

Ka Hou Christien Li , George Bazoukis , Tong Liu, Guangping Li, William K K Wu, Sunny Hei Wong, Wing Tak Wong, Yat Sun Chan, Martin C S Wong, Katharina Wassilew, Vassilios S Vassiliou, Gary Tse. Arrhythmogenic right ventricular cardiomyopathy/ dysplasia (ARVC/D) in clinical practice. J Arrhythm 2017: 21(34):11-22.

Sultan FA, Ahmed MA, Miller J, Selvanayagam JB. Arrhythmogenic right ventricular cardiomyopathy with biventricular involvement and heart failure in a 9-year old girl. J Saudi Heart Assoc. 2017;29:139–42.

Erpeng Liang, Lingmin Wu, Siyang Fan, Xiaofei Li, Feng Hu, Lihui Zheng, Xiaohan Fan, Gang Chen, Ligang Ding, Yan Yao. Bradyarrhythmias in Arrhythmogenic Right Ventricular Cardiomyopathy Am J Cardiol. 2019;123:1690-1695.

Julia H. Indik and Frank I. Marcus. Arrhythmogenic Right Ventricular Cardiomyopathy / Dysplasia. Indian Pacing and Electrophysiology Journal. Available: www.ipej.org

Kimura Y, Noda T, Matsuyama TA, Otsuka Y, Kamakura T, Wada M, et al. Heart failure in patients with arrhythmogenic right ventricular cardiomyopathy: What are the risk factors?Int J Cardiol. 2017;241:288-294.

Schinkel AF. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/ cardiomyopathy: Patient outcomes, incidence of appropriate and inappropriate interventions, and complications. Circ Arrhythm Electrophysiol. 2013;6:562–8.

Corrado D, Wichter T, Link MS, et al. Treatment of arrhythmogenic right ventricular cardiomyopathy/ dysplasia: An international task force consensus statement. Eur Heart J. 2015;36: 3227–37.

Wlodarska EK, Wozniak O, Konka M, Rydlewska-Sadowska W, Biederman A, Hoffman P. Thromboembolic complications in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Europace. 2006;8:596–600.

Danielle E Burghouwt, Janneke AE Kammeraad, Paul Knops, Frederik A du Plessis, Natasja MS de Groot, Bradyarrhythmias: First Presentation of Arrhythmogenic Right Ventricular Cardiomyopathy? J Clin Med Res. 2015;7:278-281.

Kirubakaran S, Bisceglia C, Silberbauer J, et al. Characterization of the arrhythmogenic substrate in patients with arrhythmogenic right ventricular cardiomyopathy undergoing ventricular tachycardia ablation. Europace. 2017;19: 1049–62.

Pu JL, Wang HT, Liu TK, Ma KJ, Li N, Yao Y, Chu JM, et al. [Clinical and ECG features of arrhythmogenic right ventricular cardiomyopathy: a retrospective analysis of 31 cases]. Zhonghua Xin Xue Guan Bing Za Zhi. 2007;35:24-27.